(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine

CAS: 1226781-44-7

Ref. 3D-FD103522

Produktinformation

• Name: (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine
• Synonyme: (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine, 2H-Pyran-3-amine, 2-(2,5-difluorophenyl)-5-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-, (2R,3S,5R)-, Mk-3102

Beschreibung

(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine is a pyrazole derivative that binds to the enzyme dipeptidyl peptidase IV (DPP IV) and inhibits the activity of dipeptidyl peptidase I (DPP I). The inhibition of these enzymes leads to an increase in insulin secretion. This drug has been shown to be effective against type 2 diabetes mellitus and metabolic disorders. It also shows efficacy in reducing postprandial blood glucose levels. The binding affinity was determined using a matrix effect. The inhibitor binding constants were found by analytical methods. Blood sampling was done for concentration-time curves to determine the pharmac

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 398.43 g/mol
• Formel: C₁₇H₂₀F₂N₄O₃S
• Reinheit: Min. 95%